Accesswire
15 Oct 2025, 00:00 UTC · 47w ago
Onco-Innovations Announces Private Placement
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
Accesswire
15 Oct 2025, 00:00 UTC · 47w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
2 claims · each scored for market impact
Onco-Innovations intends to complete a non-brokered private placement of up to 1,428,572 units at $1.40 per unit for gross proceeds of up to $2,000,000. — While the capital infusion supports operations, private placements typically cause immediate share dilution for existing holders.
-0.30The company appointed Mr. Christopher Gulka, a CFA and CPA with 30 years of capital markets experience, to its Board of Directors. — Adding a director with deep financial and corporate finance expertise is generally viewed as a positive for governance and fundraising strategy.
+0.20Which stocks this story touches
The company is raising up to $2 million in capital for R&D and operational growth and has appointed an experienced financial professional to its Board.
Continue reading
5 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
13h ago
